医薬品開発受託機関・CRO向け臨床試験情報
質の高い情報とデータベースの提供を通じて、CROのビジネス獲得と医薬品開発サービスの強化を支援します。臨床試験の計画および実施に際して、よりデータに基づいた意思決定を行えるようになります。
質の高い情報とデータベースの提供を通じて、CROのビジネス獲得と医薬品開発サービスの強化を支援します。臨床試験の計画および実施に際して、よりデータに基づいた意思決定を行えるようになります。
.jpg?w=362)
インフォーマ・ファーマインテリジェンスは世界のCRO（医薬品開発受託機関）上位10社と医薬品企業上位50社を含む3,000社以上のお客様にサービスを提供しています。
リード探索からターゲット設定、提案準備、実現可能性の評価、スポンサーとのミーティング、臨床試験の実施まで。より多くのビジネスを勝ち取り、臨床試験の最適化を手助けする情報を提供します。
TrialScope Disclose helps you navigate the ever-changing complexities of clinical trial disclosure — mitigating regulatory risk and maximizing transparency.
Key benefits:
Citeline Engage: Supporting clinical trial planning and exec...
14 Sep 2021
Created by the European Medicines Agency (EMA). Stakeholders will use CTIS to: Submit and approve clinical trial applications (CTAs), Submit trial reports, results and notifications, Communicate centrally with the Member States Concerned (MSC) in the clinical trial
Topic Policy & Regulation Clinical Trials Clinical Trials Blog
Citeline Connect
22 Jul 2021
Informa Pharma Intelligence partnered with Rare Patient Voice to measure the pulse of the public in relation to clinical trial participation post-COVID-19
Topic clinical-trials
Trial Results Summaries
19 Apr 2021
Trial Results Summaries provides an unbiased and non-promotional portal for sponsors to share trial results summaries, also known as plain language summaries (PLS), with participants and the public.
Topic Clinical Trials
27 Nov 2020
Depression affects approximately 1 in 6 Americans, with 10 – 30% of depression patients becoming treatment-resistant. Find out what the pipeline looks like for depression and what the emerging strategies in this area are. This data-packed whitepaper from Informa Pharma Intelligence can now be downloaded – free.
09 Oct 2020
Join our panel of experts as they discuss the impact of COVID-19 on clinical trials, the new normal and future pathways to get ahead. Get the latest insights and status on recent clinical trials, the emergence of virtual trials, and what you need to know for success.
Citeline
15 Sep 2020
Listen to our podcast “The Future of Clinical Trials From the Investigator Perspective” from earlier this year and register for our upcoming webinar to learn new developments
Topic Clinical Trials Coronavirus
09 Jun 2020
See how Citeline Engage can help you at every stage of your clinical trial
03 Jul 2019
With opioid abuse and deaths in the US at an all-time high, the journey to battle the opioid epidemic continues – keeping drug companies and the FDA working hard to come up with effective alternatives for pain.
Sitetrove: 治験責任医師と治験施設情報のデータベース, Trialtrove: 医療用医薬品の臨床試験情報デー...
02 Jul 2019
Citeline is the industry’s most comprehensive, reliable and up-to-date global clinical trial intelligence suite, designed to help you save time and money by enrolling patients faster. Our team of more than 250 industry experts transform data into knowledge, integrating robust drug, trial, investigator, and site intelligence.
Heidi Chen 11 Jun 2019
Twenty years ago, there was a shift in pain management, and it became more common to prescribe opioids for chronic pain.
Pharmaprojects: 医薬品開発パイプラインのデータベース
11 Jun 2019
Take the analysis from the Informa Pharma Intelligence R&D Annual Review 2019 further with the Pharma R&D Annual Review 2019 Supplement: New Active Substances Launched During 2018. This essential whitepaper uses critical data from Pharmaprojects to examine the new entities that were successfully launched to market last year.
Citeline
By Avery Levine 10 Apr 2019
While AIDS therapy was once confined to palliative care, clinical progress in the wake of the landmark 1987 approval of zidovudine has seen HIV demoted to a chronic but manageable infection. Following the initial fledgling steps and missteps, the mid-1990s saw the introduction of the now-familiar three-drug combination regimens that raised expectations for a pharmaceutical solution to the epidemic.
Topic Infectious diseases
Trialtrove: 医療用医薬品の臨床試験情報データベース
By Laura Runkel 19 Oct 2018
Explore the current and future outlook for rheumatoid arthritis (RA) treatments. Such treatments remain ineffective for the 33% of RA sufferers who are or become unresponsive to treatment, resulting in a high interest in RA drug development to address this unmet need in the marketplace.
Citeline
17 Jul 2017
Using exclusive data from Citeline’s Trialtrove, part of the Informa Pharma Intelligence suite of tools, our analysts will go beyond the numbers and dig into the granular details and their implications.
Topic clinical-trials
29 Jun 2017
We've made the valuable and trustworthy content of Sitetrove and Trialtrove even better via the enhanced features of the new platform.
製品説明＆デモお申込
専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。
＊一部のサービスでは無料トライアルをご利用になれません。
お問い合わせ先
新型コロナウイルス感染拡大防止のため在宅勤務を実施しています。お問い合わせの際は下記のフォームまたはメールアドレスをご利用下さい。
Eメール：inquiry.jp@informa.com
レポートストア
オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。
お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。